Mark Ware
Dr Mark Ware is currently the Chief Medical Officer of Canopy Growth Corporation. He has taken a leave of absence as Associate Professor in Family Medicine and Anesthesia at McGill University from July 2018 to work in this capacity. He previously served as Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre for over 10 years and was the Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids since 2007. He has served as co-director of the FRQS-supported Quebec Pain Research Network and sat on the executive management team …
Dr Mark Ware is currently the Chief Medical Officer of Canopy Growth Corporation. He has taken a leave of absence as Associate Professor in Family Medicine and Anesthesia at McGill University from July 2018 to work in this capacity.
He previously served as Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre for over 10 years and was the Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids since 2007.
He has served as co-director of the FRQS-supported Quebec Pain Research Network and sat on the executive management team of the Alan Edwards Centre for Research on Pain at McGill University. His research has been funded and supported by CIHR, FRQS, private foundations and pharmaceutical companies.
He has published over 100 papers on cannabis and pain research in academic journals, has written 6 book chapters, and has given hundreds of lectures to health professionals and the public on cannabis over the last 20 years. He has served as a consultant to several large corporate and academic research programs internationally. He has advised the Canadian federal government on cannabis policy since 2001, and 2016, he served as the vice chair of the Federal Task Force on the Legalization and Regulation of Cannabis in Canada.
See more
He previously served as Director of Clinical Research of the Alan Edwards Pain Management Unit at the McGill University Health Centre for over 10 years and was the Executive Director of the non-profit Canadian Consortium for the Investigation of Cannabinoids since 2007.
He has served as co-director of the FRQS-supported Quebec Pain Research Network and sat on the executive management team of the Alan Edwards Centre for Research on Pain at McGill University. His research has been funded and supported by CIHR, FRQS, private foundations and pharmaceutical companies.
He has published over 100 papers on cannabis and pain research in academic journals, has written 6 book chapters, and has given hundreds of lectures to health professionals and the public on cannabis over the last 20 years. He has served as a consultant to several large corporate and academic research programs internationally. He has advised the Canadian federal government on cannabis policy since 2001, and 2016, he served as the vice chair of the Federal Task Force on the Legalization and Regulation of Cannabis in Canada.
Articles: Mark Ware
Cannabis: The Emergence of a New Paradigm in Healthcare
Canada / Mark Ware, the Chief Medical Officer of Canopy Growth Corporation, has intensely investigated the effects of cannabinoids, making him perfectly placed to cover this new era of cannabis in healthcare. I propose that the renaissance of cannabis under varying regulatory frameworks actually represents a paradigm shift in health care, and these varied responses reflect different…
Latest Report
